C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/64 (2006.01) A61K 31/4412 (2006.01) A61P 3/10 (2006.01) A61P 5/48 (2006.01) A61P 9/10 (2006.01) C07D 213/80 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01)
Patent
CA 2436854
aP2 inhibiting compounds are provided having the formula wherein A, Q, and X are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing such aP2 inhibitor or a combination of such aP2 inhibitor and another antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.
L'invention concerne des composés inhibant des aP2, présentant la formule dans laquelle A, Q, et X sont tels que définis dans la description. L'invention concerne également une méthode permettant de traiter des diabètes et des maladies associées, en particulier les diabètes de type II, à l'aide d'un tel inhibiteur de aP2 ainsi que d'un autre agent antidiabétique, tel que la metformine, la glyburide, la troglitazone et/ou l'insuline.
Robl Jeffrey A.
Sulsky Richard
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Pyridone derivatives as ap2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridone derivatives as ap2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridone derivatives as ap2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1410463